SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-031137
Filing Date
2022-11-09
Accepted
2022-11-09 17:00:45
Documents
17
Period of Report
2022-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55445
2 ex10-1.htm EX-10.1 63777
3 ex10-2.htm EX-10.2 60972
4 ex17-1.htm EX-17.1 6476
5 ex17-2.htm EX-17.2 4165
6 ex99-1.htm EX-99.1 11870
  Complete submission text file 0001493152-22-031137.txt   404564

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE imun-20221103.xsd EX-101.SCH 3257
8 XBRL LABEL FILE imun-20221103_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE imun-20221103_pre.xml EX-101.PRE 22379
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3299
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 221373526
SIC: 2834 Pharmaceutical Preparations